U.S. pharmaceutical giant Moderna will build a new mRNA Innovation and Technology Center in the UK in partnership with the UK government, with the aim to start producing vaccines in 2025.
Announcing the deal on Wednesday, British Prime Minister Boris Johnson said the UK’s first mRNA research and manufacturing centre will give the country access to “supercharged, homegrown vaccines,” “guarantee jabs in arms against some of the toughest viruses out there,” and create jobs.
